Goals of statin therapy: Three viewpoints

Gilbert R. Thompson, Christopher J. Packard, Neil J. Stone

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations


The "lipid hypothesis" is now universally recognized as a law. Few issues in medicine are as completely resolved as the question of whether reducing serum cholesterol increases longevity. However, there are a few questions that remain, and the most important uncertainty is to what extent cholesterol should be reduced. The medical community, in partnership with government and industry, has contributed many excellent trials demonstrating the effects in patients with elevated cholesterol (above the mean). Where should our goal of therapy be? Until data is available from several large, ongoing trials, we do not have a final answer. We asked three investigators, Drs. Gilbert Thompson, Christopher Packard, and Neil Stone, who have all been integrally involved in the accumulation of our present database, to argue three different possible answers.

Original languageEnglish (US)
Pages (from-to)26-33
Number of pages8
JournalCurrent atherosclerosis reports
Issue number1
StatePublished - Jan 2002

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Goals of statin therapy: Three viewpoints'. Together they form a unique fingerprint.

Cite this